全文获取类型
收费全文 | 1900篇 |
免费 | 132篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 66篇 |
妇产科学 | 10篇 |
基础医学 | 154篇 |
口腔科学 | 78篇 |
临床医学 | 166篇 |
内科学 | 372篇 |
皮肤病学 | 24篇 |
神经病学 | 198篇 |
特种医学 | 302篇 |
外科学 | 215篇 |
综合类 | 21篇 |
一般理论 | 14篇 |
预防医学 | 191篇 |
眼科学 | 44篇 |
药学 | 103篇 |
肿瘤学 | 95篇 |
出版年
2021年 | 15篇 |
2019年 | 13篇 |
2018年 | 33篇 |
2017年 | 14篇 |
2016年 | 12篇 |
2015年 | 15篇 |
2014年 | 25篇 |
2013年 | 47篇 |
2012年 | 55篇 |
2011年 | 58篇 |
2010年 | 55篇 |
2009年 | 41篇 |
2008年 | 60篇 |
2007年 | 74篇 |
2006年 | 64篇 |
2005年 | 75篇 |
2004年 | 65篇 |
2003年 | 37篇 |
2002年 | 36篇 |
2001年 | 65篇 |
2000年 | 67篇 |
1999年 | 72篇 |
1998年 | 75篇 |
1997年 | 68篇 |
1996年 | 44篇 |
1995年 | 48篇 |
1994年 | 38篇 |
1993年 | 32篇 |
1992年 | 45篇 |
1991年 | 48篇 |
1990年 | 39篇 |
1989年 | 53篇 |
1988年 | 53篇 |
1987年 | 46篇 |
1986年 | 58篇 |
1985年 | 51篇 |
1984年 | 35篇 |
1983年 | 32篇 |
1982年 | 19篇 |
1981年 | 18篇 |
1980年 | 28篇 |
1979年 | 35篇 |
1978年 | 17篇 |
1977年 | 25篇 |
1976年 | 33篇 |
1975年 | 15篇 |
1973年 | 16篇 |
1972年 | 14篇 |
1971年 | 12篇 |
1968年 | 12篇 |
排序方式: 共有2059条查询结果,搜索用时 15 毫秒
1.
2.
Golli M; Van Nhieu JT; Mathieu D; Zafrani ES; Cherqui D; Dhumeaux D; Vasile N; Rahmouni A 《Radiology》1994,190(3):741
3.
4.
5.
6.
MGC Hendriks P Dogterom JT Ebels B Oosterhuis LR Geertsema T Hulot G Bianchetti and JHG Jonkman 《Fundamental & clinical pharmacology》1998,12(5):559-565
Summary— In the present study we have compared the steady state biopharmaceutic characteristics of four diltiazem once daily controlled release capsules: Mono-Tildiem LP 300® (300 mg), Adizem® XL (300 mg)1, Cardizem® (300 mg) and Dilacor® (240 mg). Sixteen healthy male volunteers (aged 22.9 ± 3.3 years, range 19–31 years) completed an open label, multiple oral dose, randomized, four-period crossover study without a washout period in between. The volunteers received each diltiazem formulation once daily for four days. Trough diltiazem and metabolites plasma concentrations were determined on days 3 and 4. The 24-h plasma concentration-time profiles were assessed after the dose on day 4 of each period. The following steady state pharmacokinetic parameters for diltiazem were calculated: the minimum plasma concentration (cmin), the maximum plasma concentration (cmax), the time to reach that concentration (tmax), the time interval during which the plasma concentration exceeds 50% of cmax (t50), the area under the plasma concentration-time curve (AUC72–96) and the peak-to-trough fluctuation (PTF). For the metabolites of diltiazem, N-mono-desmethyl-diltiazem (NDM) and desacetyldiltiazem (DAD), AUC72–96 (AUCNDM and AUCDAD) and the ratio metabolite/parent compound were calculated. Steady state was achieved on day 3. Except one, all controlled release formulations have satisfactory controlled release properties allowing once daily administration. However, significant (P < 0.05) differences were found between the pharmacokinetic characteristics which do not allow exchange of the various formulations. Concentrations well below 50 ng·mL-1 in the morning hours were observed for Dilacor® (240 mg) and Adizem® XL (300 mg), which could be a disadvantage of these formulations as it is well-known that ischaemic events occur at a higher rate during that part of the day. The plasma concentration profiles of NDM and DAD, the major circulating metabolites, parallel the plasma concentration profiles for the parent compound. From a clinical point of view, all treatments were well tolerated. 相似文献
7.
8.
Intestinal obstruction proximal to a transition zone without an interposed physical barrier usually indicates Hirschsprung disease. The authors report one case of focal small bowel muscular thinning just distal to a transition zone that produced clinical and radiographic findings that simulated long-segment Hirschsprung disease in a 2-day-old infant. 相似文献
9.
Daffertshofer M Huang Z Fatar M Popolo M Schroeck H Kuschinsky W Moskowitz MA Hennerici MG 《Neuroscience letters》2004,361(1-3):115-119
The key goal in the treatment of acute ischemic stroke is fast vessel recanalization. Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is efficient in humans but mean time for recanalization is within hours. Ultrasound bio-effects has been shown to facilitate rt-PA mediated thrombolysis in peripheral arteries. We used an embolic stroke model in the rat. In all rats we induced an ischemic stroke by a selective occlusion of the middle cerebral artery with whole blood clots. From an entire collective of 54 rats 47 completed the protocol (n = 7 died early). Four different groups (no treatment n = 6; full dose rt-PA treatment only [10 mg/kg per body weight] n = 14, half dose rt-PA treatment plus ultrasound n = 10, and full dose rt-PA treatment plus ultrasound n = 17) were investigated. We found a significant reduction of absolute as well as relative infarct volume in the full dose rt-PA plus ultrasound group (81+/-72 mm(3); P< 0.05) in comparison to untreated rats (253+/-159 mm(3); P < 0.05) as well as in comparison to rats treated with full dose rt-PA only (167+/-91 mm(3); P < 0.05). There were five intracranial bleedings giving a bleeding rate of 9.3%. In summary: ultrasound treatment in addition to rt-PA is more effective than single rt-PA treatment in reducing infarct volume and safe with regard to bleeding. 相似文献
10.
Louise Bergeron Gloria I. Perez Glen Macdonald Lianfa Shi Yi Sun Andrea Jurisicova Sue Varmuza Keith E. Latham Jodi A. Flaws Jessica C.M. Salter Hideaki Hara Michael A. Moskowitz En Li Arnold Greenberg Jonathan L. Tilly Junying Yuan 《Genes & development》1998,12(9):1304-1314
During embryonic development, a large number of cells die naturally to shape the new organism. Members of the caspase family of proteases are essential intracellular death effectors. Herein, we generated caspase-2-deficient mice to evaluate the requirement for this enzyme in various paradigms of apoptosis. Excess numbers of germ cells were endowed in ovaries of mutant mice and the oocytes were found to be resistant to cell death following exposure to chemotherapeutic drugs. Apoptosis mediated by granzyme B and perforin was defective in caspase-2-deficient B lymphoblasts. In contrast, cell death of motor neurons during development was accelerated in caspase-2-deficient mice. In addition, caspase-2-deficient sympathetic neurons underwent apoptosis more effectively than wild-type neurons when deprived of NGF. Thus, caspase-2 acts both as a positive and negative cell death effector, depending upon cell lineage and stage of development. 相似文献